Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Authors: Mummery CJ; Dementia Research Centre, National Hospital for Neurology and Neurosurgery, University College London, London, UK. c.mummery@ucl.ac.uk., Börjesson-Hanson A; Karolinska University Hospital, ME Aging, Stockholm, Sweden., Blackburn DJ; Sheffield Teaching Hospital NHS Foundation Trust, NIHR Sheffield Clinical Research Facility and NIHR Sheffield Biomedical Research Centre, Royal Hallamshire Hospital, Sheffield, UK., Vijverberg EGB; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., De Deyn PP; University Medical Center Groningen / RUG, Alzheimer Center Groningen, Groningen, the Netherlands., Ducharme S; Douglas Mental Health University Institute and McConnell Brain Imaging Centre of the Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada., Jonsson M; Memory Clinic, Psychiatry - Cognition and Geriatric Psychiatry, Sahlgrenska University Hospital, Gothenburg/Molndal, Sweden., Schneider A; German Center for Neurodegenerative Diseases, DZNE, and Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany., Rinne JO; CRST Oy; Turku PET Centre University of Turku and Turku University Hospital, Turku, Finland., Ludolph AC; Department of Neurology University of Ulm and DZNE, Ulm, Germany., Bodenschatz R; Pharmakologisches Studienzentrum Chemnitz GmbH Mittweida, Mittweida, Germany., Kordasiewicz H; Ionis Pharmaceuticals, Carlsbad, CA, USA., Swayze EE; Ionis Pharmaceuticals, Carlsbad, CA, USA., Fitzsimmons B; Ionis Pharmaceuticals, Carlsbad, CA, USA., Mignon L; Ionis Pharmaceuticals, Carlsbad, CA, USA., Moore KM; Ionis Pharmaceuticals, Carlsbad, CA, USA., Yun C; Ionis Pharmaceuticals, Carlsbad, CA, USA., Baumann T; Ionis Pharmaceuticals, Carlsbad, CA, USA., Li D; Ionis Pharmaceuticals, Carlsbad, CA, USA., Norris DA; Ionis Pharmaceuticals, Carlsbad, CA, USA., Crean R; Ionis Pharmaceuticals, Carlsbad, CA, USA., Graham DL; Biogen, Cambridge, MA, USA., Huang E; Biogen, Cambridge, MA, USA., Ratti E; Biogen, Cambridge, MA, USA., Bennett CF; Ionis Pharmaceuticals, Carlsbad, CA, USA., Junge C; Ionis Pharmaceuticals, Carlsbad, CA, USA., Lane RM; Ionis Pharmaceuticals, Carlsbad, CA, USA.
Source: Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 304.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-023-02639-3